245 related articles for article (PubMed ID: 16875385)
1. [Acute blood sugar peaks endanger blood vessels: the postprandial situation to be controlled better].
MMW Fortschr Med; 2006 Jun; 148(26):57. PubMed ID: 16875385
[No Abstract] [Full Text] [Related]
2. Diabetes. Paradoxical effects of tightly controlled blood sugar.
Taubes G
Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
[No Abstract] [Full Text] [Related]
3. [Start of insulin therapy. How to ensure patient compliance?].
MMW Fortschr Med; 2006 Aug; 148(35-36):12-3. PubMed ID: 16995354
[No Abstract] [Full Text] [Related]
4. [Intensive glucose control in type 2 diabetes is beneficial].
Nilsson PM; Attvall S
Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
[No Abstract] [Full Text] [Related]
5. [Postprandial glycemia in diabetes patients: assessing this indicator].
Letonturier P
Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
[No Abstract] [Full Text] [Related]
6. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
7. [Certain beginning of insulin therapy: yes, we can, but...].
Rohrer A
Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
[No Abstract] [Full Text] [Related]
8. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.
Kazda C; Hülstrunk H; Helsberg K; Langer F; Forst T; Hanefeld M
J Diabetes Complications; 2006; 20(3):145-52. PubMed ID: 16632233
[TBL] [Abstract][Full Text] [Related]
9. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
[TBL] [Abstract][Full Text] [Related]
10. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R
Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237
[TBL] [Abstract][Full Text] [Related]
11. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
Charpentier G; Riveline JP; Dardari D; Varroud-Vial M
Drugs; 2006; 66(3):273-86. PubMed ID: 16526817
[TBL] [Abstract][Full Text] [Related]
12. Why are we doing cardiovascular outcome trials in type 2 diabetes?
Menon V; Aggarwal B
Cleve Clin J Med; 2014 Nov; 81(11):665-71. PubMed ID: 25368216
[TBL] [Abstract][Full Text] [Related]
13. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
14. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
[TBL] [Abstract][Full Text] [Related]
15. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
16. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J
Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic control in diabetes.
Herman W
Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
[No Abstract] [Full Text] [Related]
18. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
[TBL] [Abstract][Full Text] [Related]
19. Clinical research. Deaths in diabetes trial challenge a long-held theory.
Couzin J
Science; 2008 Feb; 319(5865):884-5. PubMed ID: 18276854
[No Abstract] [Full Text] [Related]
20. Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.
Ohta A; Arai K; Nishine A; Sada Y; Kato H; Fukuda H; Asai S; Nagai Y; Katabami T; Tanaka Y
Endocr J; 2013; 60(2):173-7. PubMed ID: 23047542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]